More teens being given psychiatric medication

Increasingly, doctor visits by adolescents and young adults involve mental health diagnoses, along with the prescription of psychiatric medications.

That was the conclusion of a new study that found that in 2019, 17% of outpatient doctor visits for patients ages 13 to 24 in the United States involved a behavioral or mental health condition, including anxiety, depression, suicidal ideation, self-harm or other issues. That figure rose sharply from 2006, when just 9% of doctor’s visits involved psychiatric illnesses.

The study, published Thursday in JAMA Network Open, also found a drastic increase in the proportion of visits involving psychiatric medications. In 2019, 22.4% of outpatient visits by the 13-to-24 age group involved the prescription of at least one psychiatric drug, up from 13% in 2006.

THE BIG PICTURE

The study is the latest evidence of a shift in the kinds of ailments affecting children, adolescents and young adults. For many decades, their health care visits involved more bodily ailments, such as broken bones, viruses and drunkendriving injuries. Increasingly, however, doctors are seeing a wide variety of behavioral and mental health issues.

The reasons are not entirely clear. Some experts have said modern life presents a new kind of mental pressure, even as society has limited the risks of physical ailments.

The latest study does not posit a reason for the shift. But the pandemic alone was not to blame, it noted. “These findings suggest the increase in mental health conditions seen among youth during the pandemic occurred in the setting of already increasing rates of psychiatric illness,” wrote the authors, a pediatrician and psychiatrist at Harvard Medical School. “Treatment and prevention strategies will need to account for factors beyond the direct and indirect effects of the pandemic.”

THE NUMBERS

The analysis was drawn from the National Ambulatory Care Survey, which asks a sample of clinicians from across the country about the reasons for patient visits. Between 2006 and 2019, patients ages 13 to 24 made 1.1 billion health care visits, of which 145 million involved mental health issues. But the share of mental-health-related visits rose each year, the study found, as did

the prescription of psychiatric medications, including stimulants, antipsychotics, mood stabilizers and anti-anxiety drugs.

The study found antidepressants had the greatest increase, but it did not specify the exact level, said Dr. Florence Bourgeois, a pediatrician at Boston Children’s Hospital, an associate professor of pediatrics at Harvard Medical School and a co-author of the paper.

The prescription patterns leave an open question, she said.

“We can’t differentiate whether this speaks to the severity of conditions or changes in prescribing attitudes and trends,” she said. Either way, she added, “we are treating these conditions aggressively.”

This article originally appeared in York Times.